Regeneron gout drug works in one trial, fails other - Reuters

Regeneron gout drug works in one trial, fails other Reuters ... as a preventive therapy in 241 patients showed 160 milligrams dose of the drug decreased gout flares by 80 percent as compared to a dummy drug, ... and more »

New Phase II study in gout patients shows Novartis ACZ885 prevented acute ... - PR-inside.com (press release)

New Phase II study in gout patients shows Novartis ACZ885 prevented acute ... PR-inside.com (press release) ACZ885 significantly reduced rate of acute flares up to 75% vs. anti-inflammatory colchicine in gout patients starting uric acid lowering therapy (UALT)[1] ... and more »

Mixed Outcome For Regeneron Candidate - Daily Markets

Mixed Outcome For Regeneron Candidate Daily Markets The company is evaluating Arcalyst for preventing or treating gout flares in patients, who have undergone therapies for lowering their uric acid levels. ... and more »

New Phase II study in gout patients shows Novartis ACZ885 prevented acute ... - PipelineReview.com (press release)

New Phase II study in gout patients shows Novartis ACZ885 prevented acute ... PipelineReview.com (press release) * ACZ885 significantly reduced rate of acute flares up to 75% vs. anti-inflammatory colchicine in gout patients starting uric acid lowering therapy ...